{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:20:05Z","timestamp":1789683605125,"version":"4.0.1"},"reference-count":16,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,1,6]]},"abstract":"<jats:p>Pityriasis versicolor is one of the most frequent epidermal mycotic infections in the world, but its atrophic variant is rarely described. The aetiology of the atrophy is still unknown, and two main hypotheses have been formulated, one suggesting a correlation with long-term use of topical steroids and the other a delayed type hypersensitivity to epicutaneous antigens derived from components of the fungus. Atrophic pityriasis versicolor is a benign disease, but needs to be distinguished from other more severe skin diseases manifesting with cutaneous atrophy. The diagnosis can be easily confirmed by direct microscopic observation of the scales soaked in 15% potassium hydroxide, which reveals the typical \u2018spaghetti and meatball\u2019 appearance, or by a skin biopsy in doubtful cases. Here, we describe a case of extensive atrophic pityriasis versicolor occurring in a woman affected by Sj\u00f6gren's syndrome which completely resolved after topical antifungal treatment.<\/jats:p>","DOI":"10.1136\/bcr-2016-218108","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T15:53:53Z","timestamp":1484754833000},"page":"bcr2016218108","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Atrophic pityriasis versicolor occurring in a patient with Sj\u00f6gren's syndrome"],"prefix":"10.1136","volume":"2017","author":[{"given":"Elena","family":"Marinello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Piaserico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Alaibac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17107-9"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2340\/00015555-1316","article-title":"Skin cancer and other cutaneous disorders in liver transplant recipients","volume":"92","author":"Belloni-Fortina","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.3","first-page":"749","article-title":"Mycology\u2014an update part 2: dermatomycoses: clinical picture and diagnostics","volume":"12","author":"Nenoff","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2003.02110.x"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.5","first-page":"295","article-title":"Atrophie sur pityriasis versicolor apres corticotherapie locale prolongee","volume":"78","author":"De Graciansky","year":"1971","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5021\/ad.2010.22.4.456","article-title":"Atrophying pityriasis versicolor: is this a new variant of pityriasis versicolor?","volume":"22","author":"Yang","year":"2010","journal-title":"Ann Dermatol"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.7","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.131846"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/cup.12596","article-title":"Pityriasis versicolor atrophicans: is it true atrophy or pseudoatrophy?","volume":"43","author":"Moon","year":"2016","journal-title":"J Cutan Pathol"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.9","first-page":"740","article-title":"Atrophying tinea versicolor with epidermal atrophy","volume":"14","author":"Haiduk","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2230.1985.tb00567.x","article-title":"Pityriasis versicolor with cutaneous atrophy induced by topical steroid application","volume":"10","author":"Tatnall","year":"1985","journal-title":"Clin Exp Dermatol"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.11","first-page":"321","article-title":"[Pityriasis versicolor pseudoatrophicans. A case description]","volume":"62","author":"Wagner","year":"1987","journal-title":"Z Hautkr"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.12","first-page":"101","article-title":"Pseudoatrophic pityriasis versicolor","volume":"18","author":"Mazuecos Blanca","year":"1990","journal-title":"Med Cutan Ibero Lat Am"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.13","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12627257"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2005.01160.x"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.annder.2015.06.019","article-title":"Primary anetoderma revealing autoimmune disease","volume":"142","author":"El Moussaoui","year":"2015","journal-title":"Ann Dermatol Venereol"},{"key":"2025042702293844000_2017.jan18_1.bcr2016218108.16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000265699","article-title":"Anetoderma: is it a sign of autoimmunity?","volume":"1","author":"Al Buainain","year":"2009","journal-title":"Case Rep Dermatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-218108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T09:29:47Z","timestamp":1745746187000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-218108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,18]]},"references-count":16,"alternative-id":["10.1136\/bcr-2016-218108"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-218108","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,18]]}}}